Skip to main content

Advertisement

SpringerLink
Log in

Erythroplasia of Queyrat treated by laser and light modalities: a systematic review

  • Review Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Erythroplasia of Queyrat (EOQ) is a squamous cell carcinoma in situ most commonly located on the glans penis or prepuce. EOQ accounts for roughly 10 % of all penile malignancies and may lead to invasive squamous cell carcinoma. Standard therapy includes local excision, partial or total penectomy, cryotherapy, and topical cytotoxic agents. Treatment of EOQ has proven to be challenging due to low response rates and recurrence. In addition, radical procedures can significantly affect sexual function and quality of life. Alternative laser treatments and photodynamic therapy (PDT) offer promising results for treating EOQ. A systemic review of the literature was performed for articles discussing laser and light therapy for EOQ. Among the patients treated with the CO2 laser, 81.4 % of cases had complete remission after one session of treatment. Patients treated with PDT presented with more variable results, where 62.5 % of those treated with methyl aminolevulinate photodynamic therapy (MAL-PDT) achieved complete remission. Aminolevulinic acid (ALA-PDT) treatment showed a similar rate of remission at 58.3 %. One study utilized the Nd:YAG laser, which resulted in a recurrence of the lesion in four of the five patients treated. Of the methods reviewed, the CO2 laser offered the most promising results with a cosmetically excellent prognosis. Further studies with larger power and longer follow-up times are needed to determine the optimal treatment regimen for this penile malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kutlubay Z et al (2013) Anogenital malignancies and premalignancies: facts and controversies. Clin Dermatol 31(4):362–373

    Article  PubMed  Google Scholar 

  2. Krieg RM, Luk KH (1981) Carcinoma of penis. Review of cases treated by surgery and radiation therapy 1960–1977. Urology 18(2):149–154

    Article  CAS  PubMed  Google Scholar 

  3. Graham JH, Helwig EB (1973) Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer 32(6):1396–1414

    Article  CAS  PubMed  Google Scholar 

  4. Horenblas S et al (2000) Squamous cell carcinoma of the penis: premalignant lesions. Scand J Urol Nephrol Suppl 205:187–188

    Article  Google Scholar 

  5. Mikhail GR (1980) Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol 6(12):1027–1035

    Article  CAS  PubMed  Google Scholar 

  6. Calista D (2002) Topical cidofovir for erythroplasia of Queyrat of the glans penis. Br J Dermatol 147(2):399–400

    Article  CAS  PubMed  Google Scholar 

  7. Harrington KJ et al (1993) Erythroplasia of Queyrat treated with isotretinoin. Lancet 342(8877):994–995

    Article  CAS  PubMed  Google Scholar 

  8. Goette DK, Carson TE (1976) Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. Cancer 38(4):1498–1502

    Article  CAS  PubMed  Google Scholar 

  9. Hadway P, Corbishley CM, Watkin NA (2006) Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int 98(3):532–536

    Article  PubMed  Google Scholar 

  10. von Krogh G, Horenblas S (2000) The management and prevention of premalignant penile lesions. Scand J Urol Nephrol Suppl 205:220–229

    Google Scholar 

  11. Micali G, Nasca MR, De Pasquale R (2006) Erythroplasia of Queyrat treated with imiquimod 5% cream. J Am Acad Dermatol 55(5):901–903

    Article  PubMed  Google Scholar 

  12. Alessi SS et al (2009) Treatment of cutaneous tumors with topical 5% imiquimod cream. Clinics (Sao Paulo) 64(10):961–966

    Article  Google Scholar 

  13. Feldmeyer L et al (2011) Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat. Dermatology 223(1):52–56

    Article  CAS  PubMed  Google Scholar 

  14. Arlette JP (2003) Treatment of Bowen’s disease and erythroplasia of Queyrat. Br J Dermatol 149(Suppl 66):43–49

    Article  PubMed  Google Scholar 

  15. Orengo I, Rosen T, Guill CK (2002) Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report. J Am Acad Dermatol 47(4 Suppl):S225–S228

    Article  PubMed  Google Scholar 

  16. Micali G et al (2010) Treating skin cancer with topical cream. Expert Opin Pharmacother 11(9):1515–1527

    Article  CAS  PubMed  Google Scholar 

  17. Del Losada JP et al (2005) Erythroplasia of Queyrat with urethral involvement: treatment with carbon dioxide laser vaporization. Dermatol Surg 31(11 Pt 1):1454–1457

    PubMed  Google Scholar 

  18. Zarrabi A, Gross AJ (2011) The evolution of lasers in urology. Ther Adv Urol 3(2):81–89

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Manner H et al (2007) The tissue effect of second generation argon plasma coagulation (VIO APC) in comparison to standard APC and Nd:YAG laser in vitro. Acta Gastroenterol Belg 70(4):352–356

    PubMed  Google Scholar 

  20. Yamagami T et al (1984) Extent of thermal penetration of Nd-YAG laser—histological considerations. Neurosurg Rev 7(2–3):165–170

    Article  CAS  PubMed  Google Scholar 

  21. van Bezooijen BP et al (2001) Laser therapy for carcinoma in situ of the penis. J Urol 166(5):1670–1671

    Article  PubMed  Google Scholar 

  22. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6(1–2):143–148

    Article  CAS  PubMed  Google Scholar 

  23. Lee MR, Ryman W (2005) Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas J Dermatol 46(3):196–198

    Article  PubMed  Google Scholar 

  24. Rosemberg SK, Fuller TA (1980) Carbon dioxide rapid superpulsed laser treatment of erythroplasia of Queyrat. Urology 16(2):181–182

    Article  CAS  PubMed  Google Scholar 

  25. Rosemberg SK (1985) Carbon dioxide laser treatment of external genital lesions. Urology 25(6):555–558

    Article  CAS  PubMed  Google Scholar 

  26. Greenbaum SS et al (1989) Carbon dioxide laser treatment of erythroplasia of Queyrat. J Dermatol Surg Oncol 15(7):747–750

    Article  CAS  PubMed  Google Scholar 

  27. Ross BS et al (1998) Squamous cell carcinoma of the penis in a circumcised man: a case for dermatology and urology, and review of the literature. Cutis 61(1):41–43

    CAS  PubMed  Google Scholar 

  28. Conejo-Mir JS et al (2005) Carbon dioxide laser treatment of erythroplasia of Queyrat: a revisited treatment to this condition. J Eur Acad Dermatol Venereol 19(5):643–644

    Article  CAS  PubMed  Google Scholar 

  29. Yamaguchi Y., et al. A case of erythroplasia of Queyrat successfully treated with combination carbon dioxide laser vaporization and surgery. J Eur Acad Dermatol Venereol 2014.

  30. Stables GI et al (1999) Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 140(3):514–517

    Article  CAS  PubMed  Google Scholar 

  31. Varma S, Holt PJ, Anstey AV (2000) Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br J Dermatol 142(4):825–826

    Article  CAS  PubMed  Google Scholar 

  32. Paoli J et al (2006) Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Derm Venereol 86(5):418–421

    Article  PubMed  Google Scholar 

  33. Wang XL et al (2008) Treatment of skin cancer and pre-cancer using topical ALA-PDT—a single hospital experience. Photodiagnosis Photodyn Ther 5(2):127–133

    Article  PubMed  Google Scholar 

  34. Fai D et al (2012) Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients. J Dermatolog Treat 23(5):330–332

    Article  CAS  PubMed  Google Scholar 

  35. Park JY, Kim SJ, Kim YC (2012) Erythroplasia of Queyrat refractory to photodynamic therapy. Clin Exp Dermatol 37(7):795–797

    Article  PubMed  Google Scholar 

  36. Calzavara-Pinton PG et al (2013) A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications. Photochem Photobiol Sci 12(1):158–165

    Article  CAS  PubMed  Google Scholar 

  37. Cinotti E et al (2014) Laser photodynamic treatment for in situ squamous cell carcinoma of the glans monitored by reflectance confocal microscopy. Australas J Dermatol 55(1):72–74

    Article  PubMed  Google Scholar 

  38. Nouri K. Lasers in Dermatology and Medicine; 2012. doi:10.1007/978-0-85729-281-0.

  39. Marmur ES, Schmults CD, Goldberg DJ (2004) A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30(2):264–271

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1475 NW 12th Ave, Miami, FL, 33136, USA

    Eric L. Maranda, Vidhi V. Shah & Joaquin J. Jimenez

  2. Creighton University School of Medicine, Omaha, NE, USA

    Austin H. Nguyen & Victoria M. Lim

Authors
  1. Eric L. Maranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Austin H. Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Victoria M. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vidhi V. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joaquin J. Jimenez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric L. Maranda.

Ethics declarations

Funding sources

None

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maranda, E.L., Nguyen, A.H., Lim, V.M. et al. Erythroplasia of Queyrat treated by laser and light modalities: a systematic review. Lasers Med Sci 31, 1971–1976 (2016). https://doi.org/10.1007/s10103-016-2005-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-016-2005-9

Keywords

Search

Navigation